Eric E Yeoh

Summary

Affiliation: South Australia
Country: Australia

Publications

  1. ncbi Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial
    Eric E K Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 55:943-55. 2003
  2. ncbi Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate
    Eric E K Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide SA 5000, Australia
    Am J Gastroenterol 99:361-9. 2004
  3. ncbi 2D versus 3D radiation therapy for prostate carcinoma: a direct comparison of dose volume parameters
    Charlotte A Sale
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Acta Oncol 44:348-54. 2005
  4. ncbi Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial
    Eric E Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 81:1271-8. 2011
  5. ncbi Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function
    E E Yeoh
    Departments of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 47:915-24. 2000
  6. ncbi Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial
    Eric E Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 66:1072-83. 2006
  7. ncbi Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models
    Rungdham Takam
    School of Chemistry and Physics, The University of Adelaide, Adelaide, SA 5000, Australia
    Med Phys 37:5126-37. 2010
  8. ncbi A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2
    Ann S J Yeoh
    Department of Medical Oncology, Royal Adelaide Hospital, South Australia, Australia
    Mol Cancer Ther 6:2319-27. 2007

Detail Information

Publications8

  1. ncbi Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial
    Eric E K Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 55:943-55. 2003
    ..5 weeks) vs. a hypofractionated (55 Gy in 20 fractions within 4 weeks) schedule and to determine the efficacy of the respective treatment schedules...
  2. ncbi Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate
    Eric E K Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide SA 5000, Australia
    Am J Gastroenterol 99:361-9. 2004
    ..The prevalence and pathophysiology of anorectal dysfunction is similar after treatment with two commonly used radiation dose schedules...
  3. ncbi 2D versus 3D radiation therapy for prostate carcinoma: a direct comparison of dose volume parameters
    Charlotte A Sale
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Acta Oncol 44:348-54. 2005
    ..05 for each parameter). The area under the rectal DVH was also greater for the 3D plans (p < 0.05). These changes are attributable to the larger field sizes, particularly the length in the 3D compared with the 2D plans...
  4. ncbi Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial
    Eric E Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 81:1271-8. 2011
    ..a conventionally fractionated (64 Gy in 32 fractions within 6.5 weeks) dose schedule for radiotherapy (RT) for localized carcinoma of the prostate...
  5. ncbi Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function
    E E Yeoh
    Departments of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 47:915-24. 2000
    ..To evaluate prospectively the prevalence and pathophysiology of anorectal dysfunction following radiation therapy (RTH) for localized carcinoma of the prostate...
  6. ncbi Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial
    Eric E Yeoh
    Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Int J Radiat Oncol Biol Phys 66:1072-83. 2006
    ..a conventionally fractionated (64 Gy/32 fractions/6.5 weeks) dose schedule...
  7. ncbi Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models
    Rungdham Takam
    School of Chemistry and Physics, The University of Adelaide, Adelaide, SA 5000, Australia
    Med Phys 37:5126-37. 2010
    ..Normal tissue complication probability (NTCP) of the rectum, bladder, urethra, and femoral heads following several techniques for radiation treatment of prostate cancer were evaluated applying the relative seriality and Lyman models...
  8. ncbi A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2
    Ann S J Yeoh
    Department of Medical Oncology, Royal Adelaide Hospital, South Australia, Australia
    Mol Cancer Ther 6:2319-27. 2007
    ..Further studies investigating the molecular mechanisms underlying radiation-induced mucositis are planned to ultimately achieve anti-mucotoxic-targeted therapies...